We found that COL5A1 was highly expressed in most human cancers, including the brain and central nervous system (CNS), breast, colorectal, esophageal, gastric, head and neck, kidney, leukemia, liver, lung, lymphoma, ovarian, pancreatic, sarcoma, and other cancers. This evidence concerns the gene COL5A1 and sarcoma.